Target intelligence / Profile preview

Immunoglobulin superfamily member 1 (IGSF1)

Target
IGSF1
Molecular classification
Immunoglobulin superfamily, Cell surface glycoprotein, Membrane protein, Receptor cofactor (putative)
01

Overview

Immunoglobulin superfamily member 1 is a plasma membrane glycoprotein encoded by the IGSF1 gene on the human X chromosome[2]. This protein contains multiple immunoglobulin-like domains and is a member of the large immunoglobulin superfamily, which is characterized by cell-surface and soluble proteins involved in recognition, binding, or adhesion of cells[8]. Functionally, IGSF1 is thought to act as a coreceptor in inhibin signaling, although it is not a high-affinity inhibin receptor, and may antagonize activin A signaling in some contexts[7]. The protein is mainly expressed in the pituitary gland and brain and is crucial for normal endocrine function, especially in regulating thyroid-stimulating hormone (TSH) secretion. Mutations in IGSF1 disrupt trafficking and function of the protein, resulting in central hypothyroidism, testicular enlargement, and delayed puberty in males. Females are rarely clinically affected. There is currently no direct drug targeting IGSF1, but its deficiency is a key biomarker for the diagnosis and management of congenital central hypothyroidism[2][4][5][7].

Other names
IGSF1Immunoglobulin-like family member 1
02

Biological functions

Regulation of hormone signalingCoreceptor in inhibin signaling (putative)Antagonist of activin A signalingPotential regulation of pituitary hormone secretion
03

Disease associations

Central hypothyroidism (IGSF1 deficiency syndrome)Testicular enlargement (macroorchidism)Delayed puberty (secondary sexual characteristics)Possible implication in hepatocellular carcinoma
04

Safety considerations

Loss-of-function mutations can cause central hypothyroidism with testicular enlargement and delayed pubertyPotential incomplete penetrance and variability of phenotype
05

Biomarkers

Central hypothyroidism (diagnostic biomarker: deficiency or mutation of IGSF1)Testicular enlargement in the context of endocrine dysfunction (diagnostic marker: IGSF1 deficiency)

Beyond the preview

Go deeper on Immunoglobulin superfamily member 1 (IGSF1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin superfamily member 1 (IGSF1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call